Skip to content

Construction and community application of dietary patterns to reduce the risk of hyperlipidemia among the elderly by regional culture

Construction and community application of dietary patterns to reduce the risk of hyperlipidemia among the elderly by regional culture

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093476
Enrollment
Unknown
Registered
2024-12-05
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia in the elderly

Interventions

A dietary pattern intervention group suitable for reducing hyperlipidemia in the elderly:Nutritional Recipes for Lowering Blood Lipids
General health education control group:Health education based on the "Dietary Guidelines for Chinese Residents (2023 Edition)"

Sponsors

Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.aged 60-75 years old, permanent residents of Tianjin; 2. with borderline elevated lipids, meeting one of the following conditions: (1) 5.2 mmol/L = TC < 7.2 mmol/L; (2) 3.4 mmol/L = LDL-C < 4.9 mmol/L; (3) 1.7 mmol/L = TG < 2.3 mmol/L; (4) HDL-C < 1.0 mmol/L ; 3. Agreed to participate in the study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients diagnosed with dementia; (2) Diagnosis of tumor or psychiatric disease (e.g., depression, mania, anxiety, schizophrenia, etc.); (3) Abnormal thyroid or liver and kidney function; (4) Those with active epilepsy or severe auditory impairment who are difficult to cooperate with the investigation.

Design outcomes

Primary

MeasureTime frame
Blood lipid Test;

Secondary

MeasureTime frame
Body composition;Blood pressure;Fasting blood glucose;Serum uric acid;Urea;Creatinine;Liver function;Folic acid;Homocysteine;Carotid artery ultrasound was performed;Glycosylated Hemoglobin, Type A1C;Fasting C-peptide;Fasting INSULIN Levels;Insulin resistance index;ApoE gene polymorphism detection;MTHFR gene polymorphism detection;

Countries

China

Contacts

Public ContactWen Li

Tianjin Medical University

liwen828@tmu.edu.cn+86 159 0022 8648

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026